The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components. [electronic resource]
Producer: 20080723Description: 278-88 p. digitalISSN:- 1201-9712
- Antibodies, Bacterial -- blood
- Diphtheria -- prevention & control
- Diphtheria-Tetanus-Pertussis Vaccine -- administration & dosage
- Dose-Response Relationship, Immunologic
- Haemophilus Infections -- prevention & control
- Haemophilus Vaccines -- administration & dosage
- Haemophilus influenzae type b -- immunology
- Hepatitis B -- prevention & control
- Hepatitis B Antibodies -- blood
- Hepatitis B Vaccines -- administration & dosage
- Humans
- Immunologic Memory
- Infant
- Meningococcal Infections -- prevention & control
- Meningococcal Vaccines -- administration & dosage
- Neisseria meningitidis, Serogroup A -- immunology
- Neisseria meningitidis, Serogroup C -- immunology
- Tetanus -- prevention & control
- Treatment Outcome
- Vaccines, Combined -- administration & dosage
- Vaccines, Conjugate -- administration & dosage
- Whooping Cough -- prevention & control
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.